Frankfurt - Delayed Quote EUR
Soleno Therapeutics, Inc. (6XC.F)
64.05
+1.80
+(2.89%)
At close: May 8 at 3:29:02 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
184,429
184,429
38,670
25,109
32,259
Operating Income
-184,429
-184,429
-38,670
-25,109
-32,259
Net Non Operating Interest Income Expense
11,821
11,821
2,578
300
110
Other Income Expense
-3,242
-3,242
-2,896
742
1,239
Pretax Income
-175,850
-175,850
-38,988
-24,067
-30,910
Net Income Common Stockholders
-175,850
-175,850
-38,988
-24,067
-30,910
Diluted NI Available to Com Stockholders
-175,850
-175,850
-38,988
-24,067
-30,910
Basic EPS
-4.38
--
-2.36
-2.87
-5.81
Diluted EPS
-4.38
--
-2.36
-2.87
-5.81
Basic Average Shares
40,175.93
--
16,492.13
8,397.09
5,318.02
Diluted Average Shares
40,175.93
--
16,492.13
8,397.09
5,318.02
Total Operating Income as Reported
-187,671
-187,671
-41,384
-24,397
-31,528
Total Expenses
184,429
184,429
38,670
25,109
32,259
Net Income from Continuing & Discontinued Operation
-175,850
-175,850
-38,988
-24,067
-30,910
Normalized Income
-172,608
-172,608
-36,092
-24,809
-32,149
Interest Income
12,052
12,052
2,578
300
110
Interest Expense
231
231
0
0
--
Net Interest Income
11,821
11,821
2,578
300
110
EBIT
-175,619
-175,619
-38,988
-24,067
-32,259
EBITDA
-173,632
-173,632
-37,030
-22,103
-30,296
Reconciled Depreciation
1,987
1,987
1,958
1,964
1,963
Net Income from Continuing Operation Net Minority Interest
-175,850
-175,850
-38,988
-24,067
-30,910
Total Unusual Items Excluding Goodwill
-3,242
-3,242
-2,896
742
1,239
Total Unusual Items
-3,242
-3,242
-2,896
742
1,239
Normalized EBITDA
-170,390
-170,390
-34,134
-22,845
-31,535
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 8/28/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
328.SG MeiraGTx Holdings PLC
4.8000
+0.42%
22Z.SG Zealand Pharma A/S
59.96
-0.40%
J90.MU NurExone Biologic Inc
0.4130
-3.28%
25I.SG ImmuPharma PLC
0.0295
-1.67%
BT3.BE Lineage Cell Therapeutics Inc
0.3840
+2.67%
XUPB.F Genfit S.A.
3.8000
-1.04%
GNFTF Genfit S.A.
3.5400
0.00%
SCP.F Scancell Holdings plc
0.0950
-1.04%
XRP2.SG Silence Therapeutics PLC
3.0200
-5.63%
AYJ.HA Valneva SE
2.8500
-1.99%